Fulton Breakefield Broenniman LLC Reduces Stock Holdings in Danaher Corporation $DHR

Fulton Breakefield Broenniman LLC lowered its position in Danaher Corporation (NYSE:DHRFree Report) by 27.9% in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 48,301 shares of the conglomerate’s stock after selling 18,647 shares during the quarter. Fulton Breakefield Broenniman LLC’s holdings in Danaher were worth $11,057,000 at the end of the most recent reporting period.

Other hedge funds have also recently modified their holdings of the company. JPL Wealth Management LLC purchased a new stake in shares of Danaher in the third quarter valued at about $25,000. WFA of San Diego LLC purchased a new stake in shares of Danaher in the second quarter valued at about $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Danaher in the second quarter valued at about $27,000. ANTIPODES PARTNERS Ltd purchased a new stake in shares of Danaher in the third quarter valued at about $27,000. Finally, TruNorth Capital Management LLC purchased a new stake in shares of Danaher in the third quarter valued at about $28,000. Hedge funds and other institutional investors own 79.05% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently issued reports on DHR shares. Argus set a $265.00 price objective on shares of Danaher in a report on Wednesday, January 14th. Robert W. Baird set a $251.00 target price on shares of Danaher in a research note on Thursday, January 29th. Guggenheim increased their target price on shares of Danaher from $250.00 to $275.00 and gave the stock a “buy” rating in a research note on Friday, January 2nd. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Danaher in a research note on Friday, March 27th. Finally, Jefferies Financial Group increased their target price on shares of Danaher from $255.00 to $265.00 and gave the stock a “buy” rating in a research note on Wednesday, January 28th. Seventeen investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average target price of $253.79.

Get Our Latest Stock Analysis on Danaher

Insider Activity

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the stock in a transaction dated Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the sale, the executive vice president owned 5,099 shares of the company’s stock, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 11.10% of the company’s stock.

Danaher Trading Up 0.5%

Shares of DHR stock opened at $192.07 on Tuesday. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.87 and a quick ratio of 1.51. The firm has a market cap of $135.93 billion, a PE ratio of 38.11, a price-to-earnings-growth ratio of 2.59 and a beta of 0.95. The company has a 50-day moving average of $203.60 and a two-hundred day moving average of $214.60. Danaher Corporation has a 1-year low of $171.00 and a 1-year high of $242.80.

Danaher (NYSE:DHRGet Free Report) last issued its quarterly earnings results on Tuesday, January 27th. The conglomerate reported $2.23 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.14 by $0.09. The business had revenue of $6.84 billion for the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a net margin of 14.71% and a return on equity of 10.81%. The business’s quarterly revenue was up 4.6% on a year-over-year basis. During the same quarter in the prior year, the company earned $2.14 earnings per share. On average, analysts predict that Danaher Corporation will post 7.63 EPS for the current year.

Danaher Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Friday, March 27th will be given a dividend of $0.40 per share. This is a boost from Danaher’s previous quarterly dividend of $0.32. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. Danaher’s dividend payout ratio is currently 31.75%.

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Read More

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.